blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1779852

EP1779852 - PROCESSES FOR THE PRODUCTION OF SILDENAFIL BASE AND CITRATE SALT [Right-click to bookmark this link]
Former [2007/18]Methods for the production of sildenafil base and citrate salt
[2007/19]
StatusThe application is deemed to be withdrawn
Status updated on  23.09.2011
Database last updated on 05.04.2025
Most recent event   Tooltip23.09.2011Application deemed to be withdrawnpublished on 26.10.2011  [2011/43]
Applicant(s)For all designated states
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
5 Basel Street, P.O. Box 3190
49131 Petah Tiqva / IL
[N/P]
Former [2007/18]For all designated states
TEVA PHARMACEUTICAL INDUSTRIES LTD.
5 Basel Street, P.O. Box 3190
49131 Petah Tiqva / IL
Inventor(s)01 / Braude, Viviana
Haharuv Street 19
60920, Kadima / IL
02 / Aronhime, Judith
Rehov Harav Maor Iosef 5a
76217, Rehovot / IL
03 / Shabat, Shalom
Marganit Street 3
Yavne / IL
 [2007/18]
Representative(s)Eder, Michael
df-mp Patentanwälte Rechtsanwälte PartG mbB
Theatinerstraße 16
80333 München / DE
[N/P]
Former [2007/18]Eder, Michael
Dörries, Frank-Molnia & Pohlman, Triftstrasse 13
80538 München / DE
Application number, filing date07101908.705.01.2005
[2007/18]
Priority number, dateUS20040534527P05.01.2004         Original published format: US 534527 P
US20040547232P23.02.2004         Original published format: US 547232 P
US20040549268P01.03.2004         Original published format: US 549268 P
[2007/18]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1779852
Date:02.05.2007
Language:EN
[2007/18]
Type: A3 Search report 
No.:EP1779852
Date:09.05.2007
[2007/19]
Search report(s)(Supplementary) European search report - dispatched on:EP05.04.2007
ClassificationIPC:A61K31/519, A61P15/10, C07D487/04
[2007/19]
CPC:
A61K31/519 (EP); A61P15/10 (EP); C07D487/04 (EP)
Former IPC [2007/18]A61K31/519
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/18]
TitleGerman:PROZESSE ZUR HERSTELLUNG VON SILDENAFIL-BASE UND ZITRATSALZ[2007/19]
English:PROCESSES FOR THE PRODUCTION OF SILDENAFIL BASE AND CITRATE SALT[2007/19]
French:PROCEDES DE FABRICATION DE SILDENAFIL BASE ET DE SON SEL CITRATE[2007/19]
Former [2007/18]Verfahren zur Herstellung von Sildenafil-Base und Zitratsalz
Former [2007/18]Methods for the production of sildenafil base and citrate salt
Former [2007/18]Procédés de production d'une base de sildenafil et de sel de citrate
Examination procedure08.11.2007Examination requested  [2007/51]
13.12.2007Despatch of a communication from the examining division (Time limit: M06)
23.06.2008Reply to a communication from the examining division
20.08.2008Observations by third parties
21.12.2010Despatch of a communication from the examining division (Time limit: M04)
03.05.2011Application deemed to be withdrawn, date of legal effect  [2011/43]
09.06.2011Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2011/43]
Parent application(s)   TooltipEP05705020.5  / EP1633364
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20050705020) is  10.05.2006
Fees paidRenewal fee
07.02.2007Renewal fee patent year 03
14.01.2008Renewal fee patent year 04
25.03.2008Renewal fee patent year 05
22.01.2010Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.01.201107   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]EP0463756  (PFIZER LTD [GB], et al) [Y] 12-15,18-26 * page 4, line 30 - page 5, line 1; example 12 *;
 [A]EP0812845  (PFIZER LTD [GB], et al) [A] 15-26 * (IV) --> (V); page 5 *;
 [Y]WO9849166  (PFIZER LTD [GB], et al) [Y] 12-15,18-26 * Examples; page 8, line 8 - line 10; claim 20 *;
 [X]US2002013464  (DUNN PETER JAMES [GB], et al) [X] 12-26 * paragraph [0074]; example 3d *;
 [Y]WO02102802  (KOREA INST SCI & TECH [KR], et al) [Y] 12-15,18-26 * page 7, line 1 - line 11 *;
 [PX]WO2004072079  (PFIZER LTD [GB], et al) [PX] 1-11* claims 1-12 *;
 [X]  - ADMOUR I M ET AL, "SOLID MODIFACTIONS IN SILDENAFIL CITRATE", WORLD MEETING APV/APGI, (20000403), pages 639 - 640, XP001180790 [X] 1-11,27-34 * the whole document *
 [T]  - DUNN P J, "SYNTHESIS OF COMMERCIAL PHOSPHODIESTERASE(V) INHIBITORS", ORGANIC PROCESS RESEARCH AND DEVELOPMENT, CAMBRIDGE, GB, (20050601), vol. 9, no. 1, pages 88 - 97, XP009052967 [T] 1-11,27-34 * Scheme 1 *
 [X]  - SHENYANG YAOKE DAXUE XUEBAO - SHENYANG PHARMACEUTICAL UNIVERSITY.JOURNAL, LIAONING,, CN, (200205), vol. 19, no. 3, ISSN 1006-2858, pages 173 - 175, XP001206087 [X] 1-11,27-34 * figure 1 *
other   - "Biopharmaceutics - Principles of pharmaceutical processing", LACHMAN L. ET AL, The Theory and practice of industrial Pharmacy, PHILADELPHIA, LEA & FEBRIGER, (1970), pages 1, 251 - 252, ISBN 8121-0148-0, XP003023310
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.